Other adipokines, such as resistin, seem to be involved in insulin resistance, while tumor necrosis factor alfa (TNF-α) and IL-6, which may be present at early and late stages of NAFLD, increase expression of SREBP-1c in the liver and further promote insulin resistance (21). This evidence concerns the gene SREBF1 and metabolic dysfunction-associated steatotic liver disease.